1. Home
  2. CVAC
  3. CVAC News

Latest CureVac N.V. (CVAC) News on October 18, 2025

CureVac (NasdaqGM:CVAC) Valuation in Focus After Recent Share Price Movements
CVAC

Simply Wall St.

a month ago

CureVac (NasdaqGM:CVAC) Valuation in Focus After Recent Share Price Movements

CureVac N.V. (CVAC) Has Gained Over 16% In One Month. Here Is Why
CVAC

Insider Monkey

3 months ago

CureVac N.V. (CVAC) Has Gained Over 16% In One Month. Here Is Why

CureVac Announces Voting Results of General Meeting
CVAC

ACCESS Newswire

4 months ago

CureVac Announces Voting Results of General Meeting

CureVac Soars 41% in a Month on a $1.25B Buyout Offer From BioNTech
CVAC

Zacks

4 months ago

CureVac Soars 41% in a Month on a $1.25B Buyout Offer From BioNTech

Oracle reports Q4 beat, BioNTech to acquire CureVac: Morning Buzz
CVAC

TipRanks

4 months ago

Oracle reports Q4 beat, BioNTech to acquire CureVac: Morning Buzz

BioNTech buys mRNA, courtroom rival CureVac in all-stock deal
CVAC

BioPharma Dive

4 months ago

BioNTech buys mRNA, courtroom rival CureVac in all-stock deal

CVAC

MT Newswires

4 months ago

Jefferies Downgrades CureVac to Hold From Buy, $5 Price Target

Stocks to Watch Recap: Boeing, Oracle, GE Aerospace, GameStop
CVAC

The Wall Street Journal

4 months ago

Stocks to Watch Recap: Boeing, Oracle, GE Aerospace, GameStop

CVAC

MT Newswires

4 months ago

Top Midday Gainers

CVAC

MT Newswires

4 months ago

Sector Update: Health Care

BioNTech bolsters mRNA pipeline with $1.25bn CureVac acquisition
CVAC

Pharmaceutical Technology

4 months ago

BioNTech bolsters mRNA pipeline with $1.25bn CureVac acquisition

Gold prices, BioNTech to acquire CureVac, Tapestry upgrade
CVAC

Yahoo Finance Video

4 months ago

Gold prices, BioNTech to acquire CureVac, Tapestry upgrade

Top Stock Movers Now: Oracle, Boeing, CureVac, and More
CVAC

Investopedia

4 months ago

Top Stock Movers Now: Oracle, Boeing, CureVac, and More

CVAC

MT Newswires

4 months ago

Top Midday Stories: Boeing Shares Fall After Air India Plane Crash; Oracle Q4 Results Top Expectations

We Think CureVac's (NASDAQ:CVAC) Robust Earnings Are Conservative
CVAC

Simply Wall St.

5 months ago

We Think CureVac's (NASDAQ:CVAC) Robust Earnings Are Conservative

CureVac First Quarter 2025 Earnings: Misses Expectations
CVAC

Simply Wall St.

5 months ago

CureVac First Quarter 2025 Earnings: Misses Expectations

Earnings Beat: CureVac N.V. (NASDAQ:CVAC) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
CVAC

Simply Wall St.

5 months ago

Earnings Beat: CureVac N.V. (NASDAQ:CVAC) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

CureVac Announces Financial Results for the First Quarter of 2025 and Provides Business Updates
CVAC

ACCESS Newswire

5 months ago

CureVac Announces Financial Results for the First Quarter of 2025 and Provides Business Updates

May 2025's Promising Penny Stocks To Consider
CVAC

Simply Wall St.

5 months ago

May 2025's Promising Penny Stocks To Consider

CVAC

MT Newswires

6 months ago

UBS Trims Price Target on CureVac to $12 From $13, Maintains Buy Rating

CureVac Among 3 Promising Penny Stocks To Watch
CVAC

Simply Wall St.

6 months ago

CureVac Among 3 Promising Penny Stocks To Watch

Prada to acquire Versace, CarMax reports mixed Q4 results: Morning Buzz
CVAC

TipRanks

6 months ago

Prada to acquire Versace, CarMax reports mixed Q4 results: Morning Buzz

CureVac NV (CVAC) Q4 2024 Earnings Call Highlights: Strategic Partnerships and Financial Resilience
CVAC

GuruFocus.com

6 months ago

CureVac NV (CVAC) Q4 2024 Earnings Call Highlights: Strategic Partnerships and Financial Resilience

CVAC

Thomson Reuters StreetEvents

6 months ago

Q4 2024 CureVac NV Earnings Call

CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2024 and Provides Business Update
CVAC

ACCESS Newswire

6 months ago

CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2024 and Provides Business Update

CureVac to Report Fourth Quarter and Full-Year 2024 Financial Results and Business Update on April 10, 2025
CVAC

ACCESS Newswire

6 months ago

CureVac to Report Fourth Quarter and Full-Year 2024 Financial Results and Business Update on April 10, 2025

FDA clears CureVac’s IND application for Phase I lung cancer trial
CVAC

Clinical Trials Arena

6 months ago

FDA clears CureVac’s IND application for Phase I lung cancer trial

CVAC

MT Newswires

6 months ago

CureVac Receives FDA Clearance to Initiate Phase 1 Trial of Lung Cancer Therapy

CureVac Receives U.S. FDA IND Clearance to Initiate Phase 1 Clinical Trial for Novel mRNA-Based Precision Immunotherapy in Squamous Non-Small Cell Lung Cancer
CVAC

ACCESS Newswire

6 months ago

CureVac Receives U.S. FDA IND Clearance to Initiate Phase 1 Clinical Trial for Novel mRNA-Based Precision Immunotherapy in Squamous Non-Small Cell Lung Cancer

Is CureVac (CVAC) the Best German Stock to Buy According to Hedge Funds?
CVAC

Insider Monkey

7 months ago

Is CureVac (CVAC) the Best German Stock to Buy According to Hedge Funds?

Lululemon reports Q4 beat, CoreWeave IPO priced at $40: Morning Buzz
CVAC

TipRanks

7 months ago

Lululemon reports Q4 beat, CoreWeave IPO priced at $40: Morning Buzz

CVAC

MT Newswires

7 months ago

Sector Update: Health Care

CVAC

MT Newswires

7 months ago

CureVac Patent Validated in BioNTech Dispute, Infringement Hearing Set for July

CureVac Receives Positive Validity Decision from European Patent Office in Litigation Against BioNTech SE
CVAC

ACCESS Newswire

7 months ago

CureVac Receives Positive Validity Decision from European Patent Office in Litigation Against BioNTech SE

CureVac N.V.'s (NASDAQ:CVAC) largest shareholders are individual investors with 38% ownership, private equity firms own 31%
CVAC

Simply Wall St.

7 months ago

CureVac N.V.'s (NASDAQ:CVAC) largest shareholders are individual investors with 38% ownership, private equity firms own 31%

Is CureVac N.V. (CVAC) the Best Get Rich Fast Stock to Buy Now?
CVAC

Insider Monkey

8 months ago

Is CureVac N.V. (CVAC) the Best Get Rich Fast Stock to Buy Now?

CureVac Earns Repeat Recognition by LexisNexis(R) as One of the World’s Top Innovators
CVAC

ACCESS Newswire

8 months ago

CureVac Earns Repeat Recognition by LexisNexis(R) as One of the World’s Top Innovators

Discovering Giftify And 2 Other US Penny Stocks With Promising Potential
CVAC

Simply Wall St.

8 months ago

Discovering Giftify And 2 Other US Penny Stocks With Promising Potential

Companies Like CureVac (NASDAQ:CVAC) Are In A Position To Invest In Growth
CVAC

Simply Wall St.

9 months ago

Companies Like CureVac (NASDAQ:CVAC) Are In A Position To Invest In Growth

Moderna stock forfeits gains as first US bird flu death puts vaccine development in focus
CVAC

Yahoo Finance

9 months ago

Moderna stock forfeits gains as first US bird flu death puts vaccine development in focus

Moderna stock seesaws as first US bird flu death puts vaccine development in focus
CVAC

Yahoo Finance

9 months ago

Moderna stock seesaws as first US bird flu death puts vaccine development in focus

Vaccine Stocks Jump After CDC Reports First US Bird-Flu Death
CVAC

Zacks

9 months ago

Vaccine Stocks Jump After CDC Reports First US Bird-Flu Death

Moderna Stock Jumps Amid Bird Flu Vaccine Hope After First U.S. Death
CVAC

Barrons.com

9 months ago

Moderna Stock Jumps Amid Bird Flu Vaccine Hope After First U.S. Death

Discover 3 US Penny Stocks With Market Caps Over $200M
CVAC

Simply Wall St.

10 months ago

Discover 3 US Penny Stocks With Market Caps Over $200M

Cerus And 2 Other US Penny Stocks To Watch
CVAC

Simply Wall St.

a year ago

Cerus And 2 Other US Penny Stocks To Watch

Loss-Making CureVac N.V. (NASDAQ:CVAC) Set To Breakeven
CVAC

Simply Wall St.

a year ago

Loss-Making CureVac N.V. (NASDAQ:CVAC) Set To Breakeven

Is the Options Market Predicting a Spike in CureVac (CVAC) Stock?
CVAC

Zacks

a year ago

Is the Options Market Predicting a Spike in CureVac (CVAC) Stock?

Is CureVac N.V. (CVAC) the Best German Stock to Buy Now?
CVAC

Insider Monkey

a year ago

Is CureVac N.V. (CVAC) the Best German Stock to Buy Now?

Where are they now? 4 biotechs that soared then crashed during the pandemic
CVAC

Pharma Voice

a year ago

Where are they now? 4 biotechs that soared then crashed during the pandemic

CureVac NV (CVAC) Q3 2024 Earnings Call Highlights: Strong Financial Performance and Strategic ...
CVAC

GuruFocus.com

a year ago

CureVac NV (CVAC) Q3 2024 Earnings Call Highlights: Strong Financial Performance and Strategic ...

CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update
CVAC

ACCESSWIRE

a year ago

CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update

CureVac to Report Third Quarter and First Nine Months 2024 Financial Results and Business Update on November 12, 2024
CVAC

ACCESSWIRE

a year ago

CureVac to Report Third Quarter and First Nine Months 2024 Financial Results and Business Update on November 12, 2024

CVAC

MT Newswires

a year ago

CureVac Appoints Axel Sven Malkomes as CFO

CureVac Strengthens Leadership Team with Appointment of Seasoned Industry Executive Axel Sven Malkomes as Chief Financial Officer
CVAC

ACCESSWIRE

a year ago

CureVac Strengthens Leadership Team with Appointment of Seasoned Industry Executive Axel Sven Malkomes as Chief Financial Officer

CureVac to Present at the 12th International mRNA Health Conference
CVAC

ACCESSWIRE

a year ago

CureVac to Present at the 12th International mRNA Health Conference

US Penny Stocks To Watch In October 2024
CVAC

Simply Wall St.

a year ago

US Penny Stocks To Watch In October 2024

GSK Cuts Vaccine Sales Outlook Amid U.S. Weakness
CVAC

The Wall Street Journal

a year ago

GSK Cuts Vaccine Sales Outlook Amid U.S. Weakness

CureVac to Present at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting
CVAC

ACCESSWIRE

a year ago

CureVac to Present at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting

CVAC

Morningstar Research

a year ago

Analyst Report: CureVac N.V.

CVAC

MT Newswires

a year ago

Pfizer, BioNTech Win Legal Dispute Against CureVac's UK COVID Patents

Pfizer, BioNTech win bid to invalidate CureVac's UK COVID vaccine patents
CVAC

Reuters

a year ago

Pfizer, BioNTech win bid to invalidate CureVac's UK COVID vaccine patents

CureVac N.V.'s (NASDAQ:CVAC) top owners are individual investors with 35% stake, while 31% is held by private equity firms
CVAC

Simply Wall St.

a year ago

CureVac N.V.'s (NASDAQ:CVAC) top owners are individual investors with 35% stake, while 31% is held by private equity firms

CVAC

MT Newswires

a year ago

CureVac Says CVGBM Cancer Vaccine Induces 77% T-Cell Response in Early-Stage Trial in Glioblastoma

CureVac's CVGBM Cancer Vaccine Induces Promising Immune Responses in Phase 1 Study in Glioblastoma Presented at the ESMO 2024 Congress
CVAC

ACCESSWIRE

a year ago

CureVac's CVGBM Cancer Vaccine Induces Promising Immune Responses in Phase 1 Study in Glioblastoma Presented at the ESMO 2024 Congress

GSK's HSV Vaccine Study Fails to Meet Primary Efficacy Goal
CVAC

Zacks

a year ago

GSK's HSV Vaccine Study Fails to Meet Primary Efficacy Goal

CureVac Partner GSK Announces Positive Phase 2 Data from Seasonal Influenza mRNA Vaccine Program
CVAC

ACCESSWIRE

a year ago

CureVac Partner GSK Announces Positive Phase 2 Data from Seasonal Influenza mRNA Vaccine Program

CureVac to Present First CVGBM Glioblastoma Cancer Vaccine Clinical Data at ESMO 2024 Congress
CVAC

ACCESSWIRE

a year ago

CureVac to Present First CVGBM Glioblastoma Cancer Vaccine Clinical Data at ESMO 2024 Congress

News Flash: 8 Analysts Think CureVac N.V. (NASDAQ:CVAC) Earnings Are Under Threat
CVAC

Simply Wall St.

a year ago

News Flash: 8 Analysts Think CureVac N.V. (NASDAQ:CVAC) Earnings Are Under Threat

CureVac Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
CVAC

Simply Wall St.

a year ago

CureVac Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

CVAC

Morningstar Research

a year ago

Analyst Report: CureVac N.V.

CVAC

MT Newswires

a year ago

CureVac Doses First Patient in Part B of Cancer Vaccine Candidate Study

CVAC

MT Newswires

a year ago

CureVac's Q2 Pre-Tax Loss Widens, Revenue Rises; Finance Chief Pierre Kemula to Depart

CureVac Announces Financial Results for the Second Quarter and First Half of 2024 and Provides Business Update
CVAC

ACCESSWIRE

a year ago

CureVac Announces Financial Results for the Second Quarter and First Half of 2024 and Provides Business Update

CureVac Advances Cancer Vaccine Candidate CVGBM to Part B of Phase 1 Study in Patients with Resected Glioblastoma
CVAC

ACCESSWIRE

a year ago

CureVac Advances Cancer Vaccine Candidate CVGBM to Part B of Phase 1 Study in Patients with Resected Glioblastoma

CureVac Names Oncologist and Drug Development Expert Dr. Mehdi Shahidi to Supervisory Board
CVAC

ACCESSWIRE

a year ago

CureVac Names Oncologist and Drug Development Expert Dr. Mehdi Shahidi to Supervisory Board

CorMedix (CRMD) Reports Q2 Loss, Tops Revenue Estimates
CVAC

Zacks

a year ago

CorMedix (CRMD) Reports Q2 Loss, Tops Revenue Estimates

CureVac N.V. (CVAC) Expected to Beat Earnings Estimates: Should You Buy?
CVAC

Zacks

a year ago

CureVac N.V. (CVAC) Expected to Beat Earnings Estimates: Should You Buy?

We Think CureVac (NASDAQ:CVAC) Can Afford To Drive Business Growth
CVAC

Simply Wall St.

a year ago

We Think CureVac (NASDAQ:CVAC) Can Afford To Drive Business Growth

CureVac (CVAC) Upgraded to Buy: What Does It Mean for the Stock?
CVAC

Zacks

a year ago

CureVac (CVAC) Upgraded to Buy: What Does It Mean for the Stock?

CVAC

MT Newswires

a year ago

CureVac Provides Trial Dates for Patent Litigation Against Pfizer, BioNTech

CureVac Provides Update on Trial Dates for Patent Litigation Across Multiple Geographies Against Pfizer/BioNTech
CVAC

ACCESSWIRE

a year ago

CureVac Provides Update on Trial Dates for Patent Litigation Across Multiple Geographies Against Pfizer/BioNTech

An Intrinsic Calculation For CureVac N.V. (NASDAQ:CVAC) Suggests It's 47% Undervalued
CVAC

Simply Wall St.

a year ago

An Intrinsic Calculation For CureVac N.V. (NASDAQ:CVAC) Suggests It's 47% Undervalued

CVAC

Morningstar Research

a year ago

Analyst Report: CureVac N.V.

GSK Buys Flu, COVID mRNA Jab Rights From Partner CureVac
CVAC

Zacks

a year ago

GSK Buys Flu, COVID mRNA Jab Rights From Partner CureVac

Biotech Stock Roundup: GSK, CVAC Revise Agreement, Updates From MRNA, RNAC & More
CVAC

Zacks

a year ago

Biotech Stock Roundup: GSK, CVAC Revise Agreement, Updates From MRNA, RNAC & More

CureVac announces restructuring to focus on mRNA projects
CVAC

Pharmaceutical Technology

a year ago

CureVac announces restructuring to focus on mRNA projects

CVAC

MT Newswires

a year ago

Sector Update: Health Care Stocks Fall in Afternoon Trading

GSK To Spend Up to $1.56B for Rights to Potential COVID-19, Flu Vaccines
CVAC

Investopedia

a year ago

GSK To Spend Up to $1.56B for Rights to Potential COVID-19, Flu Vaccines

CVAC

MT Newswires

a year ago

Sector Update: Health Care

GSK Will Pay Up to $1.5 Billion for CureVac’s mRNA Vaccines
CVAC

Barrons.com

a year ago

GSK Will Pay Up to $1.5 Billion for CureVac’s mRNA Vaccines

Moderna (MRNA) Secures BARDA Funding for Bird Flu Vaccine
CVAC

Zacks

a year ago

Moderna (MRNA) Secures BARDA Funding for Bird Flu Vaccine

CVAC

MT Newswires

a year ago

Sector Update: Health Care Stocks Steady Pre-Bell Wednesday

CVAC

MT Newswires

a year ago

Sector Update: Health Care

GSK to Buy COVID-19, Flu Vaccine Rights From CureVac for $1.56 Billion
CVAC

MT Newswires

a year ago

GSK to Buy COVID-19, Flu Vaccine Rights From CureVac for $1.56 Billion

CureVac cuts jobs, licenses out vaccines to GSK
CVAC

BioPharma Dive

a year ago

CureVac cuts jobs, licenses out vaccines to GSK

GSK to Buy CureVac’s Covid-19, Flu Vaccine Rights for Up to $1.56 Billion
CVAC

The Wall Street Journal

a year ago

GSK to Buy CureVac’s Covid-19, Flu Vaccine Rights for Up to $1.56 Billion

GSK and CureVac restructure mRNA vaccine development deal
CVAC

Pharmaceutical Technology

a year ago

GSK and CureVac restructure mRNA vaccine development deal

CVAC

MT Newswires

a year ago

CureVac Enters Into New Licensing Agreement With GSK; to Implement 'Significant' Restructuring; Shares Rise Pre-Bell

CureVac Initiates Strategic Restructuring to Align Resources with Focus on High-Value mRNA Pipeline Opportunities
CVAC

ACCESSWIRE

a year ago

CureVac Initiates Strategic Restructuring to Align Resources with Focus on High-Value mRNA Pipeline Opportunities

GSK and CureVac to Restructure Collaboration into New Licensing Agreement
CVAC

ACCESSWIRE

a year ago

GSK and CureVac to Restructure Collaboration into New Licensing Agreement

Share on Social Networks: